BioNexus Gene Lab (BGLC) Cash from Investing Activities (2018 - 2026)
BioNexus Gene Lab (BGLC) posted Cash from Investing Activities of -$13988.0 for Q1 2026, down 144.67% sequentially from -$5717.0 in Q4 2025, and up 10.6% YoY from -$12647.7 in Q1 2025.
BioNexus Gene Lab (BGLC) Cash from Investing Activities (2018 - 2026) Analysis & Trends
BioNexus Gene Lab has reported Cash from Investing Activities for 9 years, with the latest figure at -$13988.0 in Q1 2026.
- Quarterly Cash from Investing Activities rose 10.6% year-over-year to -$13988.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $946409.0 (up 137.25% YoY) and the FY2025 annual result came in at $944751.0, up 125.91% from the prior year.
- Cash from Investing Activities eased to -$13988.0 in Q1 2026 per BGLC's latest filing, from -$5717.0 in the prior quarter.
- Over five years, Cash from Investing Activities peaked at $994646.0 in Q3 2025 and troughed at -$1.4 million in Q4 2023.
- A 5-year average of -$52690.3 and a median of -$13988.0 in 2026 frame the typical range for Cash from Investing Activities.
- The sharpest annual moves came in 2023 and 2024: Cash from Investing Activities plunged 2756.3% in 2023, then surged 2170.31% in 2024.
- Over 5 years, Cash from Investing Activities stood at -$49903.0 in 2022, then slumped by 2756.3% to -$1.4 million in 2023, then soared by 138.9% to $554402.0 in 2024, then sank by 101.03% to -$5717.0 in 2025, then slumped by 144.67% to -$13988.0 in 2026.
- According to Business Quant data, Cash from Investing Activities over the past three periods registered -$13988.0, -$5717.0, and $994646.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Linde | 225.67 Bn | 220.77 Bn | 4.43 Bn | -1.66 Bn |
| 2 | Sherwin Williams | 84.74 Bn | 84.44 Bn | 3.34 Bn | -207.70 Mn |
| 3 | Ecolab | 78.90 Bn | 73.77 Bn | 1.95 Bn | - |
| 4 | Air Products & Chemicals | 68.19 Bn | 67.21 Bn | 1.04 Bn | -992.70 Mn |
| 5 | Ppg Industries | 25.36 Bn | 23.77 Bn | 1.81 Bn | -179.00 Mn |
| 6 | Chemical & Mining Co Of Chile | 23.48 Bn | 19.61 Bn | 778.60 Mn | - |
| 7 | LyondellBasell Industries | 21.91 Bn | 19.28 Bn | 2.04 Bn | -515.00 Mn |
| 8 | International Flavors & Fragrances | 21.51 Bn | 20.94 Bn | 853.00 Mn | -156.00 Mn |
| 9 | DuPont de Nemours | 18.83 Bn | 17.09 Bn | 639.00 Mn | 1.09 Bn |
| 10 | BioNexus Gene Lab | 2.28 Mn | -1.25 Mn | 12,982.00 | 416,140.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -13,988.00 |
| Mar 31, 2026 | -13,988.00 |
| Dec 31, 2025 | -5,717.00 |
| Dec 31, 2025 | -5,717.00 |
| Sep 30, 2025 | 994,646.00 |
| Sep 30, 2025 | 994,646.00 |
| Jun 30, 2025 | -28,532.00 |
| Jun 30, 2025 | -28,532.00 |
| Mar 31, 2025 | -15,646.00 |
| Mar 31, 2025 | -15,646.00 |
| Dec 31, 2024 | 554,402.00 |
| Dec 31, 2024 | 554,402.00 |
| Sep 30, 2024 | -203,160.00 |
| Sep 30, 2024 | -203,160.00 |
| Jun 30, 2024 | 63,310.00 |
| Jun 30, 2024 | 63,310.00 |
| Mar 31, 2024 | 3,650.00 |
| Mar 31, 2024 | 3,650.00 |
| Dec 31, 2023 | -1.43 Mn |
| Dec 31, 2023 | -1.43 Mn |